Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $78.0 million.

  • Medifast's Short-term Investments rose 917.72% to $78.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.0 million, marking a year-over-year increase of 917.72%. This contributed to the annual value of $78.0 million for FY2025, which is 917.72% up from last year.
  • Latest data reveals that Medifast reported Short-term Investments of $78.0 million as of Q4 2025, which was up 917.72% from $74.0 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Short-term Investments registered a high of $78.0 million during Q4 2025, and its lowest value of $4.1 million during Q1 2022.
  • Its 5-year average for Short-term Investments is $43.6 million, with a median of $55.5 million in 2024.
  • In the last 5 years, Medifast's Short-term Investments tumbled by 6264.76% in 2021 and then surged by 3538.65% in 2025.
  • Over the past 5 years, Medifast's Short-term Investments (Quarter) stood at $5.4 million in 2021, then fell by 24.32% to $4.1 million in 2022, then soared by 1270.5% to $55.6 million in 2023, then grew by 28.44% to $71.4 million in 2024, then grew by 9.18% to $78.0 million in 2025.
  • Its Short-term Investments was $78.0 million in Q4 2025, compared to $74.0 million in Q3 2025 and $61.0 million in Q2 2025.